New ECMO kit tested for safe transport of critical patients
NCT ID NCT07156669
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 21 times
Summary
This study will test a new ECMO device kit (Novalung ultimate kit with Xenios 2.0) in 20 adult patients with severe heart-lung failure. The goal is to see if the device safely maintains blood oxygen levels during hospital use and ground transport. Participants will be monitored closely, and the study does not involve any new drugs or treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EXTRACORPOREAL MEMBRANE OXYGENATION COMPLICATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Krankenhaus Bethanien gGmbH
Solingen, 42699, Germany
Contact Email: •••••@•••••
-
University Hospital Aachen
Aachen, 52074, Germany
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.